Back to search

Article

Discovery of two structurally distinct classes of inhibitors targeting the nuclease MUS81 and enhancing efficacy of chemotherapy in cancer cells

2025-07-27

Abstract excerpt

<h4>ABSTRACT</h4> Nucleases are emerging as promising pharmacological targets due to their essential role in maintaining genomic stability, which is crucial for cellular viability and can be exploited in the prevention and treatment of various diseases, including cancer. The conserved structure-specific endonuclease MUS81 is required for resolving branched DNA intermediates during replication, repair, and recombi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2f7932a0-a56f-5cf8-8999-d8bffae6a3f6
DOI
10.1101/2025.07.25.666773
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Discovery of two structurally distinct classes of inhibitors targeting the nuclease MUS81 and enhancing efficacy of chemotherapy in cancer cellsDOI 10.1101/2025.07.25.666773
Select a neighboring publication to make it the new centre.